| Reaction Details |
| Report a problem with these data |
| Target | Matrix Metalloproteinase-14 (MMP-14) |
| Ligand | beta-sulfonyl hydroxamate analogue, 7 |
| Substrate/Competitor | Wammp-5 |
| Meas. Tech. | MMP Inhibition Assay |
| pH | 7.4±n/a |
| Temperature | 295.15±n/a K |
| IC50 | 2370±300 nM |
| Citation | Huang, A; Joseph-McCarthy, D; Lovering, F; Sun, L; Wang, W; Xu, W; Zhu, Y; Cui, J; Zhang, Y; Levin, JI Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.Bioorg Med Chem.15:6170-81(2007)[PubMed] |
| More Info. |
Get all data from this article
, Solution Info
, Assay Method
|
| Matrix Metalloproteinase-14 (MMP-14) |
| Name | Matrix Metalloproteinase-14 (MMP-14) |
| Synonyms | EC 3.4.24.80 | MT-MMP 1 | MTMMP1| MT1-MMP | MT1MMP | MMP-X1 | Membrane-type matrix metalloproteinase 1 | Membrane-type-1 matrix metalloproteinase |
| Type | Single-pass type I membrane protein;metalloprotease |
| Mol. Mass. | n/a |
| Organism | Homo sapiens (human) |
| Description | The recombinant catalytic domain was used in the assay. |
| Residue | 177 |
| Sequence | IQGLKWQHNEITFCIQNYTPKVGEYATYEAIRKAFRVWESATPLRFREVPYAYIREGHEK
QADIMIFFAEGFHGDSTPFDGEGGFLAHAYFPGPNIGGDTHFDSAEPWTVRNEDLNGNDI
FLVAVHELGHALGLEHSSDPSAIMAPFYQWMDTENFVLPDDDRRGIQQLYGGESGFP
| |
|
| beta-sulfonyl hydroxamate analogue, 7 |
| Name | beta-sulfonyl hydroxamate analogue, 7 |
| Synonyms: | tert-butyl 4-({[4-(but-2-yn-1-ylamino)benzene]sulfonyl}methyl)-4-(hydroxycarbamoyl)piperidine-1-carboxylate |
| Type | Small organic molecule |
| Emp. Form. | C22H31N3O6S |
| Mol. Mass. | 465.563 |
| SMILES | CC#CCNc1ccc(cc1)S(=O)(=O)CC1(CCN(CC1)C(=O)OC(C)(C)C)C(=O)NO |
| Structure | |
| Wammp-5 |
| Name | Wammp-5 |
| Synonyms: | 7-methoxycoumarin-PQGL-(3-[2,4-dinitrophenyl]-L-2,3-diaminopropionyl)-AR-OH |
| Type | Fluorogenic substrate |
| Emp. Form. | n/a |
| Mol. Mass. | n/a |
| SMILES | n/a |
| Structure | |